Vesilute
Bladder bioregulator peptide from the Khavinson series. Short peptide (2-4 amino acids) that targets specific tissue for gene expression regulation and organ health optimization.
Research Status
Limited Clinical Data
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Mild redness, swelling, or itching at the injection site may occur. Typically resolves within 1-2 hours. Ensure proper site rotation and sterile injection technique to minimize risk.
Although rare, allergic reactions including rash, urticaria, or angioedema are possible with peptide products. Discontinue use immediately and seek medical attention if signs of allergy develop. Individuals with known peptide allergies should avoid use.
Occasional mild headache has been reported in some users. Typically self-resolving. Ensure adequate hydration and monitor for pattern.
Some users report temporary changes in urinary frequency or urgency during the first 1-2 weeks of use. This may reflect normalization of bladder function. Discontinue if symptoms persist or worsen.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 10-20 mcg |
| Frequency | 1x daily |
| Timing | Morning, sublingual or subcutaneous |
| Route | Subcutaneous |
Khavinson bioregulator peptide. Limited Western clinical trials; primarily used in Russia and Eastern Europe. Start at lower end (10 mcg) and assess response over 2-4 weeks. For research purposes only.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
Vesilute is a short-chain peptide bioregulator derived from bladder tissue that is proposed to support organ-specific gene expression and tissue homeostasis. The peptide is thought to act through tissue-specific signaling pathways that promote normal bladder epithelial cell function and smooth muscle tone regulation. Khavinson bioregulators are hypothesized to work via receptor-mediated mechanisms and intracellular signaling cascades that optimize tissue-specific protein synthesis and cellular repair processes.
Tissue-Specific Gene Expression
Bioregulator peptides are proposed to selectively enhance expression of genes involved in bladder epithelial integrity, smooth muscle function, and normal urinary physiology through organ-specific receptor interactions.
Cellular Homeostasis and Repair
The peptide may support normal cellular turnover and tissue regeneration in bladder epithelium through activation of intracellular signaling pathways involved in protein synthesis and cellular maintenance.
Smooth Muscle Regulation
Vesilute may promote normal contractile function and tone in bladder smooth muscle through modulation of calcium signaling and muscle-specific gene expression.
- Khavinson bioregulators are tissue-specific peptides derived from animal organ extracts
- Proposed mechanism involves selective stimulation of organ-specific gene expression and protein synthesis
- Limited peer-reviewed Western clinical data; primarily studied in Russian research institutions
- Bioregulator peptides are distinct from growth factors and do not appear to stimulate proliferation at therapeutic doses
- Mechanism of action remains incompletely characterized in English-language literature
Track your Vesilute research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Vesilute is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.